alanine has been researched along with Zoonoses in 1 studies
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.
Zoonoses: Diseases of non-human animals that may be transmitted to HUMANS or may be transmitted from humans to non-human animals.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sheahan, TP | 1 |
Sims, AC | 1 |
Graham, RL | 1 |
Menachery, VD | 1 |
Gralinski, LE | 1 |
Case, JB | 1 |
Leist, SR | 1 |
Pyrc, K | 1 |
Feng, JY | 1 |
Trantcheva, I | 1 |
Bannister, R | 1 |
Park, Y | 1 |
Babusis, D | 1 |
Clarke, MO | 1 |
Mackman, RL | 1 |
Spahn, JE | 1 |
Palmiotti, CA | 1 |
Siegel, D | 1 |
Ray, AS | 1 |
Cihlar, T | 1 |
Jordan, R | 1 |
Denison, MR | 1 |
Baric, RS | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Open-label Study to Assess the Safety of REMdesivir-HU as Eligible Novel therapY for Moderate and Severe Covid-19 Patients[NCT04610541] | Phase 3 | 2,000 participants (Anticipated) | Interventional | 2020-10-12 | Active, not recruiting | ||
Antiviral Activity and Safety of Remdesivir in Bangladeshi Patients With Severe Coronavirus Disease (COVID-19): An Open Label, Multi-Center, Randomized Controlled Trial[NCT04596839] | Phase 2 | 60 participants (Actual) | Interventional | 2020-09-04 | Completed | ||
Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections.[NCT04365725] | 84 participants (Actual) | Observational | 2020-05-05 | Completed | |||
Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19: A Descriptive, Longitudinal, Pragmatic Cohort Study[NCT04380870] | 500 participants (Anticipated) | Observational | 2020-05-11 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 other study available for alanine and Zoonoses
Article | Year |
---|---|
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Callithrix; Cell Line; Coronavirus; Epi | 2017 |
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Callithrix; Cell Line; Coronavirus; Epi | 2017 |
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Callithrix; Cell Line; Coronavirus; Epi | 2017 |
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Callithrix; Cell Line; Coronavirus; Epi | 2017 |
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Callithrix; Cell Line; Coronavirus; Epi | 2017 |
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Callithrix; Cell Line; Coronavirus; Epi | 2017 |
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Callithrix; Cell Line; Coronavirus; Epi | 2017 |
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Callithrix; Cell Line; Coronavirus; Epi | 2017 |
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Callithrix; Cell Line; Coronavirus; Epi | 2017 |
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Callithrix; Cell Line; Coronavirus; Epi | 2017 |
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Callithrix; Cell Line; Coronavirus; Epi | 2017 |
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Callithrix; Cell Line; Coronavirus; Epi | 2017 |
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Callithrix; Cell Line; Coronavirus; Epi | 2017 |
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Callithrix; Cell Line; Coronavirus; Epi | 2017 |
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Callithrix; Cell Line; Coronavirus; Epi | 2017 |
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.
Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Callithrix; Cell Line; Coronavirus; Epi | 2017 |